Childhood Burkitt Leukemia Active Not Recruiting Phase 2 / 3 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0056948 (Childhood Burkitt Leukemia)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01595048Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute LeukemiaTreatment